<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 14 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:SimSun;
panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
{font-family:SimSun;
panose-1:2 1 6 0 3 1 1 1 1 1;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
{font-family:"\@SimSun";
panose-1:2 1 6 0 3 1 1 1 1 1;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri","sans-serif";}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p
{mso-style-priority:99;
mso-margin-top-alt:auto;
margin-right:0in;
mso-margin-bottom-alt:auto;
margin-left:0in;
font-size:12.0pt;
font-family:"Times New Roman","serif";}
span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Calibri","sans-serif";
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri","sans-serif";}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal"><span style="font-size:14.0pt;font-family:"Times New Roman","serif";color:black">Dear all,<o:p></o:p></span></p>
<p class="MsoNormal" style="text-indent:.5in"><span style="font-size:14.0pt;font-family:"Times New Roman","serif";color:black"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-indent:.5in"><span style="font-size:14.0pt;font-family:"Times New Roman","serif";color:black">This post is to bring your attention to a job opportunity for crystallographer at Plexxikon Inc.<o:p></o:p></span></p>
<p class="MsoNormal" style="text-indent:.5in"><span style="font-size:14.0pt;font-family:"Times New Roman","serif";color:black"><o:p> </o:p></span></p>
<p class="MsoNormal" style="text-indent:.5in"><span style="font-size:14.0pt;font-family:"Times New Roman","serif";color:black">Plexxikon is a leader in the discovery and development of
</span><span style="font-size:14.0pt;font-family:"Times New Roman","serif";color:#222222">novel, small molecule pharmaceuticals. The company has utilized its proprietary discovery platform to successfully develop a portfolio of competitively differentiated
clinical and preclinical stage programs in a number of therapeutic areas. Plexxikon's most advanced program, Zelboraf® (vemurafenib, and formerly known as PLX4032), was approved by the FDA in 2011 and is approved in over 60 countries worldwide. Plexxikon's
demonstrated capability in discovery and early development uniquely positions the company to develop multiple commercial franchises for different therapeutic indications, and create significant value for Plexxikon and its collaborators.<o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:12.0pt;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;background:white;vertical-align:baseline">
<span style="font-size:14.0pt;font-family:"Times New Roman","serif";color:#222222">Plexxikon's novel discovery approach, combined with an experienced management and scientific team, a broad network of scientific and clinical experts, and partnerships that support
later stage development, have been key drivers of the company's success since it began operations in 2001. In April 2011, Plexxikon became a member of the Daiichi Sankyo Group, and continues to build its broad and diverse pipeline and R&D operations independently.<o:p></o:p></span></p>
<p class="MsoNormal" style="mso-margin-top-alt:12.0pt;margin-right:0in;margin-bottom:12.0pt;margin-left:0in;text-indent:.5in;background:white;vertical-align:baseline">
<span style="font-size:14.0pt;font-family:"Times New Roman","serif";color:#222222">Plexxikon is a small business with less than 75 employees and this position will be a critical member of the Structural Biology team reporting to an experienced scientist. This
is an exceptional opportunity to gain experience in structure-guided drug discovery in a successful biotech company. <o:p></o:p></span></p>
<p style="background:white"><strong><span style="font-family:"Arial","sans-serif";color:black">For job responsibilities and Position requirements, please see the following website.</span><o:p></o:p></strong></p>
<p style="background:white"><strong><span style="font-family:"Arial","sans-serif";color:black;font-weight:normal"><a href="http://careers.jobscore.com/jobs2/plexxikon/scientist-1-structural-biology/bcrJRgSYCr5zHPdG1ZS6tF?Board=CraigsList&PID=2606728">http://careers.jobscore.com/jobs2/plexxikon/scientist-1-structural-biology/bcrJRgSYCr5zHPdG1ZS6tF?Board=CraigsList&PID=2606728</a><o:p></o:p></span></strong></p>
<p class="MsoNormal"><span style="font-size:12.0pt">If you are interested, please
<b>directly</b> apply through the above link. Please don’t reply to this email.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt">Best Regards,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"> Ying Zhang<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"> Sr. Scientist<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt"> Plexxikon Inc. <o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:12.0pt;color:#1F497D"><o:p> </o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>